论文部分内容阅读
β-血小板球蛋白(β-Thromboglobin,简称β-TG)是一种血小板特异性蛋白,文献报告测定血浆中微量的β-TG含量,对于周围血管疾病,动脉、静脉血栓形成或栓塞,动脉粥样硬化及冠心病等疾病的诊断及疗效观察具有重要意义。本文测定肝炎后肝硬化患者血浆中β-TG含量,并以正常人血浆中β-TG含量作对照,以观察肝硬化患者血浆中β-TG的变化及其临床意义。材料与方法一、病例选择本组共39例,均为肝炎后肝硬化患者,男29例,女10例;年龄32～50岁32例,51～60岁7例。临床表现肝功能显著异常,白/球比例倒置,HBsAg均为阳性。所有患者均有不同程度脾脏
β-Thromboglobin (β-Thromboglobin, β-thromboglobulin for short) is a platelet-specific protein reported in the literature to measure trace β-TG content in plasma for peripheral vascular disease, arterial, venous thrombosis or embolism, Such as sclerosis and coronary heart disease diagnosis and efficacy of observation is of great significance. In this paper, β-TG levels in the plasma of patients with posthepatitic cirrhosis were measured, and β-TG content in normal plasma as a control to observe the changes of plasma β-TG in patients with cirrhosis and its clinical significance. Materials and Methods First, the selection of cases This group of 39 patients, all patients with hepatitis cirrhosis, 29 males and 10 females; aged 32 to 50 years in 32 cases, 51 to 60 years in 7 cases. Clinical manifestations of abnormal liver function, white / ball ratio inversion, HBsAg were positive. All patients have varying degrees of spleen